Skip to main content
. 2021 Aug 26;11:739171. doi: 10.3389/fonc.2021.739171

Table 2.

Causes of death of CML patients by front-line TKI treatment.

Causes of death First-line treatment Total (N = 73)
Imatinib (N = 56) 2GTKI (N = 17)
N % N % N %
CML-related 11 19.6 10 58.8 21 28.8
Other causes: 45 80.4 7 41.2 52 71.2
cardiac 11 19.6 1 5.9 12 16.4
neoplasia 11 19.6 3 17.6 14 19.2
lung 3 5.4 0 0.0 3 4.1
infections 1 1.8 0 0.0 1 1.4
neurologic 5 8.9 0 0.0 5 6.8
gastroenteric 3 5.4 2 11.8 5 6.8
other/unknown 10 17.9 1 5.9 11 15.1